Auna (NYSE:AUNA) Raised to Strong-Buy at Wall Street Zen

Key Points

• Wall Street Zen upgraded Auna to “strong buy,” but broader analyst sentiment remains cautious, with a consensus “hold” rating and an average price target of $6.97. Weiss Ratings separately maintained a “sell” rating.
• Auna shares were trading at $5.16, with a market capitalization of approximately $381.5 million. The company’s latest quarterly earnings missed estimates, reporting $0.15 per share versus the $0.26 consensus, although revenue exceeded expectations.
• Recent investor activity included new and expanded institutional positions, while the company reaffirmed 2026 revenue-growth guidance. However, Auna lowered its 2026 EBITDA outlook because of contract-related pressure in Colombia, creating near-term profitability concerns.

Auna (NYSE:AUNA - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a "buy" rating to a "strong-buy" rating in a report issued on Saturday, Wall Street Zen reports.

Separately, Weiss Ratings reaffirmed a "sell (d)" rating on shares of Auna in a research note on Monday, September 21st. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has an average rating of "Hold" and an average price target of $6.97.

Auna Stock Up 2.5%

Shares of Auna stock opened at $5.16 on Friday. The company has a quick ratio of 1.00, a current ratio of 1.08 and a debt-to-equity ratio of 1.61. Auna has a 12-month low of $4.09 and a 12-month high of $6.30. The firm has a market capitalization of $381.52 million, a PE ratio of 73.65 and a beta of 0.62. The stock's fifty day moving average is $5.21 and its 200-day moving average is $5.12.

Auna (NYSE:AUNA - Get Free Report) last released its earnings results on Friday, August 14th. The company reported $0.15 earnings per share for the quarter, missing the consensus estimate of $0.26 by ($0.11). The firm had revenue of $362.85 million during the quarter, compared to analysts' expectations of $357.39 million. Auna had a return on equity of 12.88% and a net margin of 0.44%. Equities analysts anticipate that Auna will post 0.79 earnings per share for the current year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. World Investment Advisors bought a new stake in shares of Auna in the 4th quarter worth approximately $52,000. Sanctuary Advisors LLC bought a new stake in Auna in the first quarter valued at about $71,000. Bank of America Corp DE raised its position in Auna by 255.9% in the first quarter. Bank of America Corp DE now owns 16,886 shares of the company's stock worth $93,000 after purchasing an additional 12,142 shares in the last quarter. WINTON GROUP Ltd bought a new position in shares of Auna during the 2nd quarter worth approximately $98,000. Finally, AXQ Capital LP raised its stake in Auna by 72.3% during the second quarter. AXQ Capital LP now owns 24,637 shares of the company's stock worth $126,000 after acquiring an additional 10,335 shares in the last quarter.

Trending Headlines about Auna

Here are the key news stories impacting Auna this week:

• Positive Sentiment: Auna reaffirmed its full-year 2026 revenue-growth guidance, supported by favorable third-quarter patient volumes and specialty-service trends. The company also cited signs of recovery in Mexico, which may help offset pressure elsewhere. Auna Announces Preliminary Update to Full-Year 2026 Outlook
• Positive Sentiment: The company said all conditions precedent have been fulfilled for construction of the Centro Ambulatorio Trecca in Peru under its public-private partnership with EsSalud. The milestone reduces execution uncertainty and advances a potentially important long-term growth project. Centro Ambulatorio Trecca Conditions Precedent
• Positive Sentiment: Auna’s analyst and investor day provided additional investor visibility into its strategy, operating trends and regional growth opportunities. Auna Analyst and Investor Day Transcript
• Neutral Sentiment: Analysts cited a consensus price target of $6.97, implying potential upside from the recent trading level, although target prices are estimates rather than guarantees. Auna Consensus Target Price
• Negative Sentiment: Auna lowered its 2026 EBITDA outlook because of contract-related pressure in Colombia. The reduction raises concerns about near-term profitability and margins even though revenue guidance was maintained. Auna Cuts 2026 EBITDA Outlook

About Auna

Auna SA is a Latin American healthcare company that provides integrated medical services through a network of hospitals, clinics, outpatient centers and specialized care facilities. Its operations include hospital care, ambulatory services, diagnostic testing, oncology treatment, preventive care and other medical specialties.

The company also offers healthcare plans and programs designed to provide access to medical services, including specialized oncology coverage. Auna's business model combines healthcare financing and service delivery, allowing it to serve patients across different stages of care, from prevention and diagnosis to treatment and follow-up.

Auna is headquartered in Peru and serves markets in Latin America, including Peru, Colombia and Mexico.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.